NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









PacingCure B.V.

PacingCure B.V.

Private
AmsterdamHealthcare & Life Scienceshttps://pacingcure.com/

Last Round

Grant

Nov 22, 2022

Total Funding Raised

$2.91M

Company Overview

PacingCure B.V. is a biotechnology company that develops precision gene therapies for cardiac arrhythmias and cardiomyopathies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

gene therapybiological pacemakercardiac gene therapyGTMPgene therapy medicinal productbradyarrhythmia treatmentviral vectorAAV-mediated gene transfercardiomyocyte reprogrammingprecision medicinebiotech startupregenerative medicinecardiac rhythm disorderdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PacingCure B.V. Comparables

Compare PacingCure B.V. with similar companies based on industry and business-model similarity.

PacingCure B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BioPace
80%
Medera
72%
Renova Therapeutics
69%

PacingCure B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 22, 2022
AcceleratorNov 26, 2020
Convertible DebtDec 18, 2019

Key People

Founding team and executive leadership

Frans van den Berg

Chief Executive Officer

Executive Team

PacingCure B.V. Investors

Notable investors and investment history

PacingCure B.V. investors
InvestorRounds
European Innovation Council FundGrant
Innovatiefonds Noord-HollandConvertible Debt
Life Sciences @ Work Venture ChallengeAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 22, 2022

    Secured $2.55M from the European Innovation Council Fund.

PacingCure B.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PacingCure B.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PacingCure B.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersAmsterdam
Employee Range6
Year Founded2016
Last FundingNov 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.